These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17447317)

  • 1. Anti-HIV agents. Raltegravir--other issues.
    TreatmentUpdate; 2007 Feb; 19(2):9-10. PubMed ID: 17447317
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV agents. Integrase inhibitor raltegravir makes its mark.
    TreatmentUpdate; 2007 Feb; 19(2):8-9. PubMed ID: 17447316
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-HIV agents. Raltegravir (Isentress)--results after one year.
    TreatmentUpdate; 2007; 19(6):8-9. PubMed ID: 18041152
    [No Abstract]   [Full Text] [Related]  

  • 4. Raltegravir, a new HIV integrase inhibitor.
    Gandhi RT
    AIDS Clin Care; 2007 Dec; 19(12):105. PubMed ID: 18399003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV agents. Merck's integrase inhibitor--short-term efficacy.
    TreatmentUpdate; 2006; 18(5):2-3. PubMed ID: 17205646
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA notifications. Accelerated approval for raltegravir tablets.
    AIDS Alert; 2007 Dec; 22(12):143-4. PubMed ID: 18411485
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-HIV agents. Merck integrase inhibitor.
    TreatmentUpdate; 2006; 18(4):3-4. PubMed ID: 17205652
    [No Abstract]   [Full Text] [Related]  

  • 8. Integrase inhibitor MK-0518: Merck opens expanded-access program.
    James JS
    AIDS Treat News; 2006; (419):5. PubMed ID: 17096488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV integrase inhibitors--out of the pipeline and into the clinic.
    Havlir DV
    N Engl J Med; 2008 Jul; 359(4):416-8. PubMed ID: 18650518
    [No Abstract]   [Full Text] [Related]  

  • 10. [Raltegravir an integrase inhibitor--a great leap forward within reach].
    Med Monatsschr Pharm; 2007 Nov; 30(11):419-21. PubMed ID: 18062335
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA approves raltegravir tablets.
    AIDS Patient Care STDS; 2007 Nov; 21(11):889. PubMed ID: 18240897
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV agents. New drugs--hope and a degree of caution.
    TreatmentUpdate; 2007; 19(6):9-10. PubMed ID: 18041153
    [No Abstract]   [Full Text] [Related]  

  • 13. [A clinical study with an HIV integrase inhibitor].
    Winckler T
    Pharm Unserer Zeit; 2007; 36(4):251-2. PubMed ID: 17623312
    [No Abstract]   [Full Text] [Related]  

  • 14. New drugs for HIV therapy.
    Rockstroh JK
    J HIV Ther; 2005 Dec; 10(4):66-7. PubMed ID: 16519244
    [No Abstract]   [Full Text] [Related]  

  • 15. Two new drugs for HIV infection.
    Med Lett Drugs Ther; 2008 Jan; 50(1277):2-4. PubMed ID: 18197163
    [No Abstract]   [Full Text] [Related]  

  • 16. Expanded access drug profile: raltegravir (RAL, MK-0518).
    Colquitt AR; Pham PA
    Hopkins HIV Rep; 2007 Jan; 19(1):11-2. PubMed ID: 17569171
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrase combination effective.
    AIDS Patient Care STDS; 2006 Sep; 20(9):658. PubMed ID: 16987052
    [No Abstract]   [Full Text] [Related]  

  • 18. [Raltegravir as first integrase inhibitor in an HIV-infection].
    Papendorp SG; Brinkman K
    Ned Tijdschr Geneeskd; 2009 Jan; 153(5):166-7. PubMed ID: 19256240
    [No Abstract]   [Full Text] [Related]  

  • 19. [Integrase inhibitor: raltegravir also as first line therapy].
    MMW Fortschr Med; 2010 Apr; 152(17):48. PubMed ID: 20509261
    [No Abstract]   [Full Text] [Related]  

  • 20. 48-week data on raltegravir in naive patients.
    AIDS Patient Care STDS; 2007 Sep; 21(9):703. PubMed ID: 17939211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.